Futura Medical (LON:FUM) Trading Down 5.5% – Should You Sell?

Futura Medical plc (LON:FUM)’s share price fell 5.5% during mid-day trading on Thursday . The company traded as low as GBX 0.64 and last traded at GBX 0.73. 1,248,722 shares were traded during trading, a decline of 80% from the average session volume of 6,124,176 shares. The stock had previously closed at GBX 0.77.

Futura Medical Price Performance

The firm has a market capitalization of £3.95 million, a price-to-earnings ratio of -0.24 and a beta of 0.01. The business’s fifty day simple moving average is GBX 0.96 and its 200 day simple moving average is GBX 1.13.

Futura Medical (LON:FUM) last posted its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. The company had revenue of GBX 170 million during the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. Equities research analysts expect that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.